We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$111B
AUM Growth
+$1.46B
Cap. Flow
+$2.6B
Cap. Flow %
2.33%
Top 10 Hldgs %
23.97%
Holding
4,345
New
253
Increased
2,150
Reduced
1,535
Closed
239

Sector Composition

Rank Sector Weight
1 Technology 14.74%
2 Financials 9%
3 Healthcare 8.22%
4 Consumer Discretionary 6.53%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AROC icon
3801
Archrock
AROC
$5.78B
$110K ﹤0.01%
+13,352
New +$107K
BTNB
3802
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
$110K ﹤0.01%
+11,105
New +$111K
IMMR icon
3803
Immersion
IMMR
$248M
$109K ﹤0.01%
15,900
+625
+4% +$4.66K
TRMT
3804
DELISTED
Tremont Mortgage Trust Common Shares of Beneficial Interest
TRMT
$109K ﹤0.01%
20,800
+1,500
+8% +$8.59K
SOL
3805
DELISTED
Emeren Group
SOL
$108K ﹤0.01%
+16,490
New +$118K
IPOF
3806
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
$108K ﹤0.01%
10,673
-337
-3% -$3.38K
CMU
3807
DELISTED
MFS High Yield Municipal Trust
CMU
$107K ﹤0.01%
23,415
ORIO
3808
Orion Digital Corp
ORIO
$18.7M
$107K ﹤0.01%
8,275
+439
+6% +$7.29K
MSC
3809
Studio City International Holdings
MSC
$327M
$106K ﹤0.01%
12,986
+1,000
+8% +$9.91K
PHK
3810
PIMCO High Income Fund
PHK
$875M
$105K ﹤0.01%
16,695
+1,366
+9% +$9.23K
A icon
3811
CALL
Agilent Technologies
A
$42.2B
$103K ﹤0.01%
13,400
PVLA
3812
Palvella Therapeutics
PVLA
$2.22B
$103K ﹤0.01%
250
-25
-9% -$8.71K
VLDR
3813
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$103K ﹤0.01%
17,350
-24,519
-59% -$184K
PBT
3814
Permian Basin Royalty Trust
PBT
$1.52B
$99K ﹤0.01%
17,350
SOFI icon
3815
CALL
SoFi Technologies
SOFI
$23.2B
$97K ﹤0.01%
+72,300
New +$1.13M
UONEK icon
3816
Urban One Class D
UONEK
$23.7M
$95K ﹤0.01%
1,400
CHS
3817
DELISTED
Chicos FAS, Inc.
CHS
$95K ﹤0.01%
21,235
+6,400
+43% +$36.5K
AUY
3818
DELISTED
Yamana Gold, Inc.
AUY
$95K ﹤0.01%
24,019
+2,256
+10% +$9.56K
CNDT icon
3819
Conduent
CNDT
$246M
$94K ﹤0.01%
14,318
+430
+3% +$2.95K
LOGC
3820
DELISTED
ContextLogic
LOGC
$94K ﹤0.01%
576
-80
-12% -$19.9K
EQT icon
3821
CALL
EQT Corp
EQT
$34B
$93K ﹤0.01%
+71,900
New +$1.39M
MRK icon
3822
CALL
Merck
MRK
$322B
$93K ﹤0.01%
113,600
+700
+0.6% +$53.2K
GOL
3823
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$93K ﹤0.01%
12,133
-5,421
-31% -$42.2K
OXLC
3824
Oxford Lane Capital
OXLC
$910M
$91K ﹤0.01%
+2,534
New +$91.9K
XCUR icon
3825
Exicure
XCUR
$8.92M
$91K ﹤0.01%
503
+86
+21% +$17.4K

Similar funds

Raymond James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Raymond James & Associates held 4,345 positions worth $111B, up 1.3% from $110B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2021 filing shows 253 new, 2,150 increased, 1,535 reduced and 239 closed positions. Its largest new stake was GXO Logistics: 224,392 shares worth $17.6M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $358M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2021 buy was GXO Logistics: 224,392 shares worth $17.6M.
  • Raymond James & Associates added most to Vanguard Morningstar Mid-Cap ETF in Q3 2021, an estimated $569M increase.
  • Raymond James & Associates's biggest Q3 2021 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $358M.
  • Raymond James & Associates fully exited Invesco S&P 500 Equal Weight Energy ETF in Q3 2021, selling an estimated $9.16M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $111B portfolio in Q3 2021.
  • Raymond James & Associates opened 253 new positions and closed 239 in Q3 2021.
  • Raymond James & Associates's portfolio value rose 1.3% quarter-over-quarter to $111B.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.